The longevity supplement aisle is where biology gets genuinely exciting and marketing gets genuinely slippery — often in the same sentence. The molecule names sound like the future (NAD+, Urolithin A, spermidine, fisetin), and behind each one is real, interesting science. The catch is that "interesting science" and "proven in humans" are separated by a gap the marketing rarely mentions.
So let's do the un-sexy thing and sort these four by how much human evidence actually exists — not by how good the mechanism sounds.
The Single Most Important Question
Before any longevity molecule, ask one thing: is the evidence from humans, or from mice and petri dishes? Almost every longevity ingredient has a beautiful mechanistic and animal story. Very few have robust human outcome data. That one distinction separates most of the hype from most of the substance.
NAD+ Precursors (NMN, NR)
The idea: NAD+ is a coenzyme central to cellular energy and DNA repair, and it declines with age. Precursors like NMN and NR are taken to raise NAD+ levels.
Where the evidence stands: human trials do show these precursors can raise blood NAD+ levels — that part is real. What's far less established is whether raising NAD+ translates into meaningful changes in ageing, energy or healthspan outcomes in humans. Raising a biomarker is not the same as improving a life.
Regulatory status matters here. In Australia the landscape around NMN in particular has regulatory nuance — worth knowing that "available overseas" doesn't mean "cleared for sale the same way locally." Check the current AU status before assuming a product is straightforwardly available.
Urolithin A
The idea: a compound your gut bacteria can make from ellagitannins (in pomegranate, walnuts) — but only if you host the right microbes, which many people don't. It's studied for mitophagy, the cell's process of clearing out worn-out mitochondria.
Where the evidence stands: this is one of the more credible entries, because there are actual human trials — small, but showing measures like improved muscle endurance and mitochondrial markers in older or middle-aged adults. Promising and human-tested, while still early and modest in effect size. That combination alone puts it ahead of most of the aisle.
Spermidine
The idea: a polyphenol-like compound (found in wheat germ, aged cheese, natto) linked to autophagy — cellular "self-cleaning" — which we covered as a mechanism in its own right.
Where the evidence stands: strong mechanistic and animal data, plus intriguing observational human data (populations with higher dietary spermidine intake showing associations with better outcomes). But association is not causation, and the interventional human trials are still limited. A promising signal that hasn't yet been confirmed by the kind of trial that would settle it.
Fisetin
The idea: a plant flavonoid (strawberries are a notable source) studied as a senolytic — something that helps clear "zombie" senescent cells that accumulate with age and drive inflammation.
Where the evidence stands: the senolytic story produced some of the most striking mouse results in the whole field — which is exactly why caution is warranted. Human trials are underway but early. Right now, fisetin is a fascinating research molecule, not a validated human intervention. Treat anyone selling it as "proven anti-ageing" as ahead of the science.
An Honest Ranking (by Human Evidence, Not Hype)
None of these are medicines, none are cures for ageing, and none should be treated as a substitute for the boring fundamentals that have overwhelming human evidence: sleep, resistance training, protein, cardiovascular fitness and not smoking. The single highest-yield "longevity protocol" is still the one nobody can patent. If you have a medical condition or take medications, check with your doctor before adding any of these — "natural" and "novel" both cut both ways.
Roughly, by weight of human evidence today: Urolithin A has the most direct human trial support (still modest); NAD+ precursors reliably move a biomarker but haven't shown clear outcome benefits; spermidine has suggestive observational human data awaiting confirmation; fisetin is the most mouse-dependent and the least human-tested. That ranking will change as trials read out — which is the point. Buy the evidence, not the molecule name.
Watch: A Doctor Who Changed His Mind on NAD+
Dr. Brad Stanfield (MD, New Zealand) walks through the NMN/NAD+ evidence and explains why he personally stopped taking NMN — the human data didn't justify it, even though it reliably raises NAD+ levels. It's a clean example of exactly the distinction this article is built on: moving a biomarker is not the same as improving healthspan.
We have no relationship with Dr. Stanfield or his channel — we're referencing it because he's a credentialed clinician who follows the evidence over the hype, including changing his own routine when the data doesn't hold up.
Bottom Line
Longevity supplements are the purest test of whether you can read past a mechanism to the actual evidence. The science is real and worth following. But "shows promise in early research" is the honest label for most of this aisle — and any brand that upgrades that to "clinically proven to slow ageing" has told you something useful about the brand.
Grab the free Label Decoder → — so you can tell a human trial from a mouse study before you spend a cent.
Looking for supplements that meet this standard?
Every product we recommend has been evaluated against our 6-criteria science filter — clinical evidence, doses, certifications, and more.
See our recommended products